TELMISAM HCT

This brand name is authorized in Nigeria.

Active ingredients

The drug TELMISAM HCT contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII U5SYW473RQ - TELMISARTAN
 

Telmisartan is an orally active and specific angiotensin II receptor (type AT1) antagonist. Telmisartan selectively binds the AT1 receptor. The binding is long-lasting.
 
Read more about Telmisartan
2
UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE
 

Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted.
 
Read more about Hydrochlorothiazide

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-100831 Tablet Telmisam HCT 40/12.5 Tablets TAB 40 mg; 12.5 mg 3 x 10's (in AIu-AIu blisters) Tablet 43 NF-PP-263188 TELMISAM HCT 40/12.5 TABLETS TELMISARTAN 40mg + HYDROCHLOROTHIAZIDE 12.5mg Telmisartan USP 40.0mg Hydrochlorothiazide USP 12.50mg Potassium Hydroxide USP 7.5mg Anhydrous Lactose USP 67.84mg Mannitol USP 60.0mg Crospovidone USP 44.0mg Colloidal Silicon Dioxide USP 6.0mg Sodium Starch Gylcolate USP 4.4mg Microcrystalline Cellulose USP 96.16mg Polacrillin Potassium USP 15.0mg Corn Starch USP 11.0mg Magnesium Stearate USP 5.0mg Sunset Yellow Supra IH 0.60mg A4-100831 Drugs Imported Products 3X10 Prescription Only Medicine (POM) DE-ZUBIK PHARMACEUTICAL LTD, 20, Ondo Road, Akure 8034754082 dezubikpharmaceutica@gmail.com M/S SCOTT- EDIL PHARMACIA LTD, 56 EPIP, Phase-1, Jharmajri Baddi Solan, H.P., INDIA, India 30/04/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C09DA07 Telmisartan and diuretics C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DA Angiotensin II antagonists and diuretics
Discover more medicines within C09DA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-100831

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈